This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global gene expression analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the gene expression analysis market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration (FDA), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Environmental Protection Agency (EPA), European Medicines Agency (EMA), Biotechnology Innovation Organization (BIO), International Society for Pharmaceutical Engineering (ISPE), National Institute for Health and Care Excellence (NICE), World National Center for Biotechnology Information (NCBI), International Trade Centre, Journal of Molecular Biology, Journal of Biological Chemistry (JBC), Annual Review of Genetics:, American Association for Cancer Research (AACR), the American Society of Human Genetics (ASHG), and the European Molecular Biology Organization (EMBO) among others. Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global gene expression analysis market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical & biopharmaceutical and biotechnology companies, and academic & research institutes) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East & Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the gene expression analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Bottom-up Approach
-
The key players in the industry and market have been identified through extensive secondary research.
-
The revenues generated from the gene expression analysis market business of leading players have been determined through primary and secondary research.
-
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Gene expression analysis is the systematic investigation of the activity levels of genes within a cell, tissue, or organism at a specific point in time which involves measuring and quantifying the production of RNA or protein molecules encoded by genes, which reflects the degree to which genes are being transcribed and translated into functional products. In gene expression analysis we use products & services related to analysis and measurement of gene expression. This market includes gene expression analysis products & services such as reagents & consumables, instruments, and gene expression analysis services and bioinformatics solutions.
Stakeholders
-
Pharmaceutical & Biotechnology Companies
-
Life Sciences Companies
-
Academic & Research Institutes
-
Government Institutes
-
Clinical Laboratories
-
Forensic Laboratories
-
Contract Research Organizations (CROs)
-
Agricultural & Environmental Organizations
-
Third-party Suppliers, Direct Suppliers, Distributors, and Channel Partners
-
Venture Capitalists and Investors
Report Objectives
-
To define, describe, and forecast the gene expression analysis market based on product & service, application, end user, and region.
-
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).
-
To analyze micromarkets for individual growth trends, prospects, and contributions to the overall gene expression analysis market.
-
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
-
To forecast the market size of the segments concerning six regions, namely: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.
-
To profile the key players and analyze their market shares and core competencies
-
To track and analyze competitive developments, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations.
-
To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business & product excellence strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
-
Further breakdown of the Rest of Europe gene expression analysis market, by country
-
Further breakdown of the Rest of Asia Pacific gene expression analysis market, by country
-
Further breakdown of the Rest of Latin America gene expression analysis market, by country
-
Further breakdown of the Rest of Middle East gene expression analysis market, by country
-
Further breakdown of the Rest of GCC Countries gene expression analysis market, by country
Company Information
-
Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
-
Further breakdown of the other technologies and other therapeutic area into subsegments
-
Cross-segment analysis
Growth opportunities and latent adjacency in Gene Expression Analysis Market